Astrana HealthASTH -0.62%87 PEG Ratio is 1.28 as of Jun. 26, 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review. Among 225 Healthcare Providers & Services companies, Astrana Health ranks better than 52.44% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Astrana Health's PEG Ratio or its related term are showing as below:
ASTH'
s PEG Ratio Range Over the Past 10 Years
Min: 0 Med: 0 Max: 1.29
Current: 1.28
During the past 13 years, Astrana Health's highest PEG Ratio was 1.29. The lowest was 0.00. And the median was 0.00.
ASTH's PEG Ratio is ranked better than 52.44% of 225
companies
in the Healthcare Providers & Services industry
Industry Median: 1.35
vs ASTH: 1.28
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Astrana Health (NAS:ASTH) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Astrana Health PEG Ratio Related Terms
Astrana Health PEG Ratio Historical Data
* Premium members only.
The historical data trend for Astrana Health's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Astrana Health's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health PEG Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Astrana Health's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Astrana Health (ASTH) has a PEG Ratio of 1.28 as of Jun. 26, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Astrana Health and its competitors. According to the industry distribution chart, Astrana Health ranks #107 out of 225 companies in the Healthcare Providers & Services industry, placing it in the top 47.6%.
Is Astrana Health's PEG Ratio too high?
Astrana Health's current PEG Ratio is 1.28. The Healthcare Providers & Services industry median PEG Ratio is 1.35. Astrana Health's value of 1.28 is 5.2% below this industry median. Based on the distribution chart, Astrana Health ranks #107 out of 225 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's PEG Ratio compare to MD and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #107 out of 225 companies for PEG Ratio. This puts Astrana Health in the upper half of its industry. The industry median PEG Ratio is 1.35. Astrana Health's value of 1.28 is 5.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Providers & Services company?
The median PEG Ratio among Healthcare Providers & Services companies is 1.35, based on 225 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current PEG Ratio of 1.28 is 5.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median PEG Ratio is 1.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current PEG Ratio is 1.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.21 — trading 47.5% below its estimated fair value. The current PEG Ratio is 1.28 and 5.2% below the Healthcare Providers & Services industry median of 1.35. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Astrana Health (ASTH), the current PEG Ratio is 1.28 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $43.21 is trading 47.5% below its estimated GF Value™ of $82.34.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
PEG Ratio: 1.28
GF Value™: $82.34 vs. price of $43.21 (47.5% below fair value)
Industry Position: 5.2% below the Healthcare Providers & Services median (#107 of 225)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score
Get the complete analysis for ASTH
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
